BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18343442)

  • 1. The arachidonic acid pathway and its role in prostate cancer development and progression.
    Patel MI; Kurek C; Dong Q
    J Urol; 2008 May; 179(5):1668-75. PubMed ID: 18343442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of cardiac gap junctions: the mode of action of arachidonic acid.
    Schmilinsky-Fluri G; Valiunas V; Willi M; Weingart R
    J Mol Cell Cardiol; 1997 Jun; 29(6):1703-13. PubMed ID: 9220356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pitfalls in the use of arachidonic acid oxidation products to assign lipoxygenase activity in cancer cells.
    Niknami M; Dong Q; Witting PK
    Free Radic Res; 2009 Oct; 43(10):951-6. PubMed ID: 19680997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of arachidonic acid regulatory enzymes in colorectal disease.
    Abir F; Alva S; Kaminski DL; Longo WE
    Dis Colon Rectum; 2005 Jul; 48(7):1471-83. PubMed ID: 15868226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group IIA phospholipase A as a prognostic marker in prostate cancer: relevance to clinicopathological variables and disease-specific mortality.
    Mirtti T; Laine VJ; Hiekkanen H; Hurme S; Rowe O; Nevalainen TJ; Kallajoki M; Alanen K
    APMIS; 2009 Mar; 117(3):151-61. PubMed ID: 19245588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoxygenase metabolism: roles in tumor progression and survival.
    Pidgeon GP; Lysaght J; Krishnamoorthy S; Reynolds JV; O'Byrne K; Nie D; Honn KV
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):503-24. PubMed ID: 17943411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by unsaturated fatty acids of type II secretory phospholipase A2 synthesis in guinea-pig alveolar macrophages evidence for the eicosanoid-independent pathway.
    Alaoui El Azher M; Havet N; Singer M; Dumarey C; Touqui L
    Eur J Biochem; 2000 Jun; 267(12):3633-9. PubMed ID: 10848980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention.
    Cathcart MC; Lysaght J; Pidgeon GP
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):363-85. PubMed ID: 22134655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arachidonic acid induces neuronal death through lipoxygenase and cytochrome P450 rather than cyclooxygenase.
    Kwon KJ; Jung YS; Lee SH; Moon CH; Baik EJ
    J Neurosci Res; 2005 Jul; 81(1):73-84. PubMed ID: 15931672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandins, thromboxanes, leukotrienes, and cytochrome P-450 metabolites of arachidonic acid.
    Cook JA; Geisel J; Halushka PV; Reines HD
    New Horiz; 1993 Feb; 1(1):60-9. PubMed ID: 7922394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of arachidonic acid cycle enzymes in platelet activation by low density lipoproteins].
    Vlasova II; Azizova OA
    Biull Eksp Biol Med; 1995 Oct; 120(10):376-9. PubMed ID: 8595224
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of acetylshikonin, a natural naphthoquinone, on the production of leukotriene B4 and thromboxane A2 in rat neutrophils.
    Hsu MF; Chang LC; Huang LJ; Kuo SC; Lee HY; Lu MC; Wang JP
    Eur J Pharmacol; 2009 Apr; 607(1-3):234-43. PubMed ID: 19232341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of eicosanoids in prostate cancer progression.
    Nie D; Che M; Grignon D; Tang K; Honn KV
    Cancer Metastasis Rev; 2001; 20(3-4):195-206. PubMed ID: 12085962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mRNA levels of enzymes and receptors implicated in arachidonic acid metabolism in gliomas.
    De Armas R; Durand K; Guillaudeau A; Weinbreck N; Robert S; Moreau JJ; Caire F; Acosta G; Pebet M; Chaunavel A; Marin B; Labrousse F; Denizot Y
    Clin Biochem; 2010 Jul; 43(10-11):827-35. PubMed ID: 20382140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and cyclooxygenase activity in prostate carcinogenesis: targets for chemopreventive strategies.
    Pathak SK; Sharma RA; Steward WP; Mellon JK; Griffiths TR; Gescher AJ
    Eur J Cancer; 2005 Jan; 41(1):61-70. PubMed ID: 15617991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
    Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
    BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenases, prostanoids, and tumor progression.
    Wang MT; Honn KV; Nie D
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):525-34. PubMed ID: 17763971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders.
    Phillis JW; Horrocks LA; Farooqui AA
    Brain Res Rev; 2006 Sep; 52(2):201-43. PubMed ID: 16647138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence.
    Van Patten CL; de Boer JG; Tomlinson Guns ES
    J Urol; 2008 Dec; 180(6):2314-21; discussion 2721-2. PubMed ID: 18930254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arachidonic acid metabolism and vitamin E].
    Parkhomets VP; Donchenko GV
    Ukr Biokhim Zh (1978); 1992; 64(6):3-11. PubMed ID: 1488809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.